Patrick O'Malley focuses his practice on general corporate representation of established and emerging life sciences, biotech, medical device and technology companies.

He regularly represents public companies in SEC periodic and current reporting, proxy statements, and related corporate and disclosure advice as well as in initial public and secondary offerings. Patrick also advises numerous private companies in venture capital financing and corporate governance and Board of Director matters. He has also represented both selling companies and acquirers in merger and acquisition transactions.